The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.

Costello, R; Mallet, F; Chambost, H; Sainty, D; Arnoulet, C; Gastaut, J A; Olive, D

Costello, R; Mallet, F; Chambost, H; Sainty, D; Arnoulet, C; Gastaut, J A; Olive, D.

Affiliation

Costello R; Immunologie des Tumeurs, Département d'Hématologie, Institut Paoli-Calmettes, Université de Méditerranée, Marseille, France.

Leukemia ; 13(10): 1513-8, 1999 Oct.

Article in En | MEDLINE | ID: mdl-10516751

Subject(s)

Antigens, CD34/blood; Antigens, CD; Antigens, Differentiation/blood; Leukemia, Myeloid/immunology; NAD+ Nucleosidase/blood; Neoplastic Stem Cells/immunology; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Acute Disease; Animals; Antigen-Antibody Reactions; Antineoplastic Agents/pharmacology; CD40 Antigens/blood; Cell Adhesion Molecules/physiology; Cell Differentiation/physiology; Humans; Immunophenotyping; Interferon-gamma/pharmacology; Interleukin-2/metabolism; Leukemia, Myeloid/pathology; Membrane Glycoproteins; Mice

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Neoplastic Stem Cells / Antigens, Differentiation / Leukemia, Myeloid / Antigens, CD / NAD/ Nucleosidase / Antigens, CD34 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 1999 Type: Article

Search on Google

XML

PubMed Links